American Society of Hirudotherapy

Destabilase Isopeptidase Activity

Isopeptidase domain of destabilase that cleaves cross-linked fibrin — distinct from lysozyme domain.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 26, 2026 · ASH Editorial · based on the books
  • Hementerin80 kDa
  • Hementin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • Destabilase Isopeptidase Activity12.5 kDa
Molecular weight (kilodaltons) of Destabilase Isopeptidase Activity (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
In vitro
Drug vs leech
Purified natural compound
Safety domains
Bleeding

Clinical translation limit

Destabilase's isopeptidase activity against cross-linked fibrin is documented in vitro and in limited animal studies; this does NOT establish clinical efficacy as a thrombolytic. No FDA-approved derivative exists.

Molecular Profile

Category
Fibrinolytic
Evidence tier
Preclinical
Molecular weight
12,500 Da
Source species
Hirudo medicinalis
PDB structures
6OJ9

Biological Targets

  • → ε-(γ-Glu)-Lys isopeptide bonds in cross-linked fibrin

Key Citations

  1. Kurdyumov AS et al. (2015), BMC Biochem · PMID 26589324
  2. Manuvera VA et al. (2015), Protein Expr Purif · PMID 26277552

External Resources

Related Fibrinolytic Compounds

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.